Rethinking Antioxidant Use in Breast Cancer: A Redox Decision-Node Framework for Therapeutic Risk and Translation
Breast Cancer: Targets and Therapy · 2026-11 · Volume 18 · 1-23
DOI: 10.2147/bctt.s651619 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Breast Cancer: Targets and Therapy, 2026-11. Verfasst von Yedi Herdiana und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, West Java, Indonesia. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, West Java, Indonesia.
- Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, West Java, Indonesia.
ORCID-Profile: Yedi Herdiana, Zerra Rizki Amalia Ilhamsyah
Zitieren
APA
Herdiana, Y., Ilhamsyah, Z. R. A., Haikal, F., Maharani, A., Wilar, G., & Gozali, D. (2026). Rethinking Antioxidant Use in Breast Cancer: A Redox Decision-Node Framework for Therapeutic Risk and Translation. Breast Cancer: Targets and Therapy, Volume 18, 1-23. https://doi.org/10.2147/bctt.s651619
Vancouver
Herdiana Y, Ilhamsyah ZRA, Haikal F, Maharani A, Wilar G, Gozali D. Rethinking Antioxidant Use in Breast Cancer: A Redox Decision-Node Framework for Therapeutic Risk and Translation. Breast Cancer: Targets and Therapy. 2026;Volume 18:1-23. doi:10.2147/bctt.s651619
BibTeX
@article{Herdiana2026,
author = {Herdiana, Yedi and Ilhamsyah, Zerra Rizki Amalia and Haikal, Fakih and Maharani, Anisa and Wilar, Gofarana and Gozali, Dolih},
title = {Rethinking Antioxidant Use in Breast Cancer: A Redox Decision-Node Framework for Therapeutic Risk and Translation},
journal = {Breast Cancer: Targets and Therapy},
year = {2026},
volume = {Volume 18},
pages = {1--23},
doi = {10.2147/bctt.s651619}
}
EUVIMED